Develops drugs for rare diseases like Menkes disease and rosacea.
Jun 2026Revenue $68.5M/yrExpenses $97.8M/yr
No trend
Figures by year
When will Fortress Biotech be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $68.5M and expenses $97.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $63.3M | $133M | −$70.2M |
| Dec 2024 | $57.7M | $168M | −$110M |
| Dec 2023 | $84.5M | $227M | −$142M |
| Dec 2022 | $75.7M | $279M | −$204M |
| Dec 2021 | $68.8M | $257M | −$189M |
| Dec 2020 | $45.6M | $140M | −$94.3M |
| Dec 2019 | $36.6M | $147M | −$111M |
| Dec 2018 | $26.9M | $147M | −$120M |
| Dec 2017 | $17.2M | $107M | −$89.8M |
| Dec 2016 | $16.5M | $82.2M | −$65.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.